Biaryl amide compounds reduce the inflammatory response in macrophages by regulating Dectin-1

Area of Science:

• Immunology
• Cell Biology

Background:

• Macrophages are key innate immune cells utilizing pattern recognition receptors (PRRs) to identify pathogens.
• Dectin-1 is a critical PRR for antifungal immunity, recognizing β-glucan.

Purpose of the Study:

• To discover novel biaryl amide compounds more effective than MPS 03 at inhibiting macrophage phagocytosis.
• To elucidate the cellular mechanisms underlying the action of these compounds.

Main Methods:

• Screening of MPS 03 derivatives for inhibition of zymosan phagocytosis.
• Measurement of pro-inflammatory cytokines (TNF-α, IL-6, IL-12) and nitric oxide (NO) levels.
• Analysis of MAPK signaling pathway and PRR expression, specifically Dectin-1.
• Assessment of downstream transcription factors (NFAT, AP-1, NF-κB).

Main Results:

• Four MPS 03 derivatives demonstrated significant inhibition of zymosan phagocytosis.
• Dose-dependent reduction in TNF-α, IL-6, IL-12, and NO production was observed.
• Biaryl amide compounds decreased Dectin-1 expression and downregulated NFAT, AP-1, and NF-κB signaling.

Conclusions:

• Biaryl amide compounds suppress zymosan-induced inflammatory responses by downregulating Dectin-1 expression.
• These compounds represent potential tools for inhibiting Dectin-1 in research and managing excessive inflammation.